Gapping up
In reaction to strong earnings/guidance: CFRX +4.6%
M&A news: GAME +6.6% (enters into definitive merger agreement for going private transaction at $7.10 per ADS), SNE +4.1% (will acquire some parts of OnLive), GG +3.2% (announces sale of its interest in the South Arturo Mine Project), VTR +1.7% (signed a definitive agreement to acquire privately-owned Ardent Medical Services for $1.75 bln in cash; also announces plan to spin off post-acute/skilled nursing facility portfolio)
Select metals/mining stocks trading higher: AUY +4%, KGC +3.9%, AEM +3.6%, GDX +3.2%, EGO +3.1%, ABX +3.1%, SLW +3.1%, NEM +3.1%, PAAS +2.9%, AU +2.8%, IAG +2.5%, HL +2.2%, SLV +2.1%, GLD +1.5%, FCX +1.2%
Other news: QURE +57.2% (and Bristol-Myers Squibb enter into exclusive strategic collaboration to develop gene therapies for cardiovascular diseases), CYTX +25% (announces its exclusive licensee, Lorem Vascular, has been granted regulatory clearance for the Cytori Celution System by the State FDA of the People's Republic of China), TCPI +12.8% (cont strength),CRIS +9.4% (granted orphan designation status by the FDA for C24H28N8O7S2 for the treatment of diffuse large B-cell lymphoma), CAPN +7.4% (awarded a Small Business Innovation Research Phase I grant totaling ~$220k by the National Heart, Lung, and Blood Institute, a division of the National Institutes of Health), BIOD +5.9% (announces results from a formative human factors study of its Glucagon Emergency Management device for the treatment of diabetes patients experiencing severe hypoglycemi), NBG +4.1% (opitimism in Greece with its Fin Min to meet with IMF), TSLA +3.8% (announces it delivered 10,030 cars in Q1 of 2015, a new record and 55% increase YoY), ARIA +3.1% (announces approval of iclusig in Canada),NNVC +2.7% (provides update on progress over the last quarter), SHPG +1% (comments on USPTO petitions related to LIALDA and GATTEX; will continue to defend vigorously its patents and pursue all legal options available to protect its products)
Analyst comments: LL +2.1% (upgraded to Outperform from Mkt Perform at Raymond James), SCMP +2% (initiated with a Buy at Guggenheim), RAD +1.6% (resumed with a Overweight at JP Morgan), ENTA +1.5% (initiated with a Buy at Deutsche Bank), VMW +1.4% (upgraded to Buy from Neutral at Nomura), SPLK +1.2% (upgraded to Overweight from Equal Weight at a boutique firm), BRCM +1% (added to FBR Top Picks List)
In reaction to strong earnings/guidance: CFRX +4.6%
M&A news: GAME +6.6% (enters into definitive merger agreement for going private transaction at $7.10 per ADS), SNE +4.1% (will acquire some parts of OnLive), GG +3.2% (announces sale of its interest in the South Arturo Mine Project), VTR +1.7% (signed a definitive agreement to acquire privately-owned Ardent Medical Services for $1.75 bln in cash; also announces plan to spin off post-acute/skilled nursing facility portfolio)
Select metals/mining stocks trading higher: AUY +4%, KGC +3.9%, AEM +3.6%, GDX +3.2%, EGO +3.1%, ABX +3.1%, SLW +3.1%, NEM +3.1%, PAAS +2.9%, AU +2.8%, IAG +2.5%, HL +2.2%, SLV +2.1%, GLD +1.5%, FCX +1.2%
Other news: QURE +57.2% (and Bristol-Myers Squibb enter into exclusive strategic collaboration to develop gene therapies for cardiovascular diseases), CYTX +25% (announces its exclusive licensee, Lorem Vascular, has been granted regulatory clearance for the Cytori Celution System by the State FDA of the People's Republic of China), TCPI +12.8% (cont strength),CRIS +9.4% (granted orphan designation status by the FDA for C24H28N8O7S2 for the treatment of diffuse large B-cell lymphoma), CAPN +7.4% (awarded a Small Business Innovation Research Phase I grant totaling ~$220k by the National Heart, Lung, and Blood Institute, a division of the National Institutes of Health), BIOD +5.9% (announces results from a formative human factors study of its Glucagon Emergency Management device for the treatment of diabetes patients experiencing severe hypoglycemi), NBG +4.1% (opitimism in Greece with its Fin Min to meet with IMF), TSLA +3.8% (announces it delivered 10,030 cars in Q1 of 2015, a new record and 55% increase YoY), ARIA +3.1% (announces approval of iclusig in Canada),NNVC +2.7% (provides update on progress over the last quarter), SHPG +1% (comments on USPTO petitions related to LIALDA and GATTEX; will continue to defend vigorously its patents and pursue all legal options available to protect its products)
Analyst comments: LL +2.1% (upgraded to Outperform from Mkt Perform at Raymond James), SCMP +2% (initiated with a Buy at Guggenheim), RAD +1.6% (resumed with a Overweight at JP Morgan), ENTA +1.5% (initiated with a Buy at Deutsche Bank), VMW +1.4% (upgraded to Buy from Neutral at Nomura), SPLK +1.2% (upgraded to Overweight from Equal Weight at a boutique firm), BRCM +1% (added to FBR Top Picks List)